Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The primary objective is to demonstrate the efficacy using 2 co-primary endpoints (as measured by the changes from baseline to the end of Week 16 in Western Ontario and McMaster University Osteoarthritis Index [WOMAC] pain and physical function subscales), safety, and tolerability of fulranumab subcutaneous (SC) injections as adjunctive therapy compared with placebo in subjects with signs and symptoms of osteoarthritis of the hip or knee.
Inclusion criteria
- Osteoarthritis of the hip or knee